A nontoxic Pseudomonas exotoxin A induces active immunity and passive protective antibody against Pseudomonas exotoxin A intoxication

被引:14
作者
Chen, TY
Lin, CP
Loa, CC
Chen, TL
Shang, HF
Hwang, JL [1 ]
Hui, CF
机构
[1] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan
[2] Natl Yang Ming Univ, Sch Life Sci, Inst Genet, Taipei 112, Taiwan
[3] Natl Labs Foods & Drugs, Dept Hlth, Div Drug Biol, Taipei, Taiwan
[4] Soochow Univ, Grad Sch Microbiol, Taipei, Taiwan
[5] Taipei Med Coll, Dept Med, Taipei, Taiwan
[6] Acad Sinica, Inst Zool, Taipei, Taiwan
关键词
Pseudomonas exotoxin A; vaccination;
D O I
10.1007/BF02253525
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Pseudomonas exotoxin A (PE) is one of the most potent cytotoxic agents produced by Pseudomonas aeruginosa. In this study, we examined the possibility of using PE with a deletion of 38 carboxyl-terminal amino acid residues, designated PE(Delta 576-613), for active immunization against PE-mediated disease. We first examined the toxic effects of PE and PE(Delta 576-613) on 5- and 9-week-old ICR mice, The results show that the subcutaneous administration of PE(Delta 576-613) at a dose of 250 mu g was still nontoxic to 5- and 9-week-old ICR mice, while native PE was lethal at a dose of 0.5 and 1 mu g, respectively. PE(Delta 576-613) was then used to immunize ICR mice. The minimum dose of PE(Delta 576-613) that could effectively induce anti-PE antibodies in 5- and 9-week-old ICR mice was found to be 250 ng, However, immunization with 250 ng PE(Delta 576-673) failed to protect the immunized mice from a lethal dose of PE, The effective immunization dose of PE(Delta 576-613) that could protect mice against a 2 mu g PE challenge was found to be 15 Gig. In addition, sera obtained from PE(Delta 576-613)-immunized ICR mice were able to neutralize PE intoxication and effectively protect mice from PE, Thus, PE(Delta 576-613) may be used as an alternative route to new PE vaccine development.
引用
收藏
页码:357 / 363
页数:7
相关论文
共 41 条
[1]   STRUCTURE OF EXOTOXIN-A OF PSEUDOMONAS-AERUGINOSA AT 3.0-ANGSTROM RESOLUTION [J].
ALLURED, VS ;
COLLIER, RJ ;
CARROLL, SF ;
MCKAY, DB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (05) :1320-1324
[2]   OPSONOPHAGOCYTOSIS OF PSEUDOMONAS-AERUGINOSA TREATED WITH ANTIFLAGELLAR SERUM [J].
ANDERSON, TR ;
MONTIE, TC .
INFECTION AND IMMUNITY, 1987, 55 (12) :3204-3206
[3]  
BODEY GP, 1983, REV INFECT DIS, V5, P279
[4]  
CHEN ST, 1987, J GEN MICROBIOL, V133, P3081
[5]  
CHOW JT, 1989, J BIOL CHEM, V264, P18818
[6]   EVIDENCE FOR THE ROLE OF TOXIN A IN THE PATHOGENESIS OF INFECTION WITH PSEUDOMONAS-AERUGINOSA IN HUMANS [J].
CROSS, AS ;
SADOFF, JC ;
IGLEWSKI, BH ;
SOKOL, PA .
JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (04) :538-546
[7]   SAFETY AND IMMUNOGENICITY OF A PSEUDOMONAS-AERUGINOSA O-POLYSACCHARIDE TOXIN A CONJUGATE VACCINE IN HUMANS [J].
CRYZ, SJ ;
FURER, E ;
CROSS, AS ;
WEGMANN, A ;
GERMANIER, R ;
SADOFF, JC .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (01) :51-56
[8]   PROTECTION AGAINST FATAL PSEUDOMONAS-AERUGINOSA BURN WOUND SEPSIS BY IMMUNIZATION WITH LIPOPOLYSACCHARIDE AND HIGH-MOLECULAR-WEIGHT POLYSACCHARIDE [J].
CRYZ, SJ ;
FURER, E ;
GERMANIER, R .
INFECTION AND IMMUNITY, 1984, 43 (03) :795-799
[9]  
CRYZ SJ, 1988, J LAB CLIN MED, V111, P701
[10]   VACCINE POTENTIAL OF PSEUDOMONAS-AERUGINOSA O-POLYSACCHARIDE TOXIN-A CONJUGATES [J].
CRYZ, SJ ;
LANG, AB ;
SADOFF, JC ;
GERMANIER, R ;
FURER, E .
INFECTION AND IMMUNITY, 1987, 55 (07) :1547-1551